Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 1Nervous System Diseases 1Epilepsy 1Brain Neoplasms 1

Interventions

Radiosurgery 9Temozolomide 8Magnetic Resonance Spectroscopy 5pembrolizumab 4Specimen Handling 4Nivolumab 4Bevacizumab 4Receptors, Interleukin-8B 3Memantine 3trastuzumab deruxtecan 2abemaciclib 2Watchful Waiting 2Surveys and Questionnaires 2Radiotherapy 2Radiation 2Mental Status and Dementia Tests 2Ipilimumab 2Biopsy 2sotorasib 1sapanisertib 1sacituzumab govitecan 1ribociclib 1pertuzumab 1osimertinib 1lenvatinib 1fluciclovine F-18 1entrectinib 1elacestrant 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Clinical Laboratory Techniques × 30 days × Clear all
NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡